Clinical overlap between Jakob-Creutzfeldt disease and Lewy body disease

Canadian Journal of Neurological Sciences

Volumn 39, Issue 3, 2012, Pages 304-310

  Tartaglia, Maria Carmela ^a,c   Johnson, David Y ^a   Thai, Julie Ngoc ^a   Cattaruzza, Tatiana Cattaruzza ^d   Wong, Katherine ^a   Garcia, Paul ^a   Dearmond, Stephen J ^b   Miller, Bruce L ^a   Geschwind, Michael D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BASAL GANGLION; CEREBELLUM DISEASE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; DIFFUSION WEIGHTED IMAGING; ELECTROENCEPHALOGRAM; FEMALE; HALLUCINATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MYOCLONUS; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; PARIETAL LOBE; PREDICTOR VARIABLE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SPORADIC CREUTZFELDT JAKOB DISEASE;

EID: 84860442480     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100013421     Document Type: Article

References (31)

1. Haik S, Brandel JP, Sazdovitch V, et al. Dementia with Lewy bodies in a neuropathologic series of suspected Creutzfeldt-Jakob disease. Neurology. 2000;55(9):1401-4.
2. Tschampa HJ, Neumann M, Zerr I, et al. Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry. 2001; 71(1):33-9.
3. Geschwind MD, Shu H, Haman A, Sejvar JJ, Miller BL. Rapidly progressive dementia. Ann Neurol. 2008;64(1):97-108.
4. Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol. 1999;46(2):224-33. (Pubitemid 29382879)
5. Walker Z, Allen RL, Shergill S, Mullan E, Katona CL. Three years survival in patients with a clinical diagnosis of dementia with Lewy bodies. Int J Geriatr Psychiatry. 2000;15(3):267-73. (Pubitemid 30179179)
6. Gaig C, Valldeoriola F, Gelpi E, et al. Rapidly progressive diffuse Lewy body disease. Mov Disord. 2011;26(7):1316-23.
7. Torres-Chae C, Nguyen E, Ando T, Haman A, Miller BL, MD. G. The differential of sCJD. Neurology. 2008;70:A149.
8. Shiga Y, Miyazawa K, Sato S, et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt- Jakob disease. Neurology. 2004;63(3):443-9. (Pubitemid 39031372)
9. Young GS, Geschwind MD, Fischbein NJ, et al. Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt- Jakob disease: High sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol. 2005;26(6):1551-62. (Pubitemid 43733460)
10. Vitali P,Maccagnano E, Caverzasi E, et al. Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology. 2011;76(20):1711-9.
11. Steinhoff BJ, Zerr I, Glatting M, Schulz-Schaeffer W, Poser S, Kretzschmar HA. Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease. Ann Neurol. 2004;56(5):702-8. (Pubitemid 39540751)
12. Zerr I, Brandel JP, Masullo C, et al. European surveillance on Creutzfeldt-Jakob disease: A case-control study for medical risk factors. J Clin Epidemiol. 2000;53(7):747-54. (Pubitemid 30609629)
13. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology. 2005;65(12):1863-72. (Pubitemid 43970103)
14. Budka H, Aguzzi A, Brown P, et al. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol. 1995;5(4):459-66.
15. Geschwind MD, Josephs KA, Parisi JE, Keegan BM. A 54-year-old man with slowness of movement and confusion. Neurology. 2007;69(19):1881-7. (Pubitemid 350071150)
16. WHO. Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies: Report of a WHO consultation. Paper Presented at the World Health Organization: Emerging and other communicable diseases, surveillance and control. Geneva (Switzerland); 1998
17. Zerr I, Pocchiari M, Collins S, et al. Analysis of EEG and CSF 14- 3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology. 2000;55(6):811-15.
18. Sanchez-Valle R, Saiz A, Graus F. 14-3-3 Protein isoforms and atypical patterns of the 14-3-3 assay in the diagnosis of Creutzfeldt-Jakob disease. Neurosci Lett. 2002;320(1-2):69-72. (Pubitemid 34159278)
19. Gaig C, Valldeoriola F, Gelpi E, et al. Rapidly progressive diffuse Lewy body disease. Mov Disord. 2011 [Epub ahead of print].
20. Geschwind MD, Martindale J, Miller D, et al. Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. Arch Neurol. 2003;60(6):813-16. (Pubitemid 36705966)
21. Russmann H, Vingerhoets F, Miklossy J, et al. Sporadic Creutzfeldt-Jakob disease: A comparison of pathological findings and diffusion weighted imaging. J Neurol. 2005;252(3):338-42. (Pubitemid 40562167)
22. Ukisu R, Kushihashi T, Kitanosono T, et al. Serial diffusionweighted MRI of Creutzfeldt-Jakob disease. AJR Am J Roentgenol. 2005;184(2):560-6. (Pubitemid 46657267)
23. Demaerel P, Heiner L, RobberechtW, Sciot R,Wilms G. Diffusionweighted MRI in sporadic Creutzfeldt-Jakob disease. Neurology. 1999;52(1):205-8. (Pubitemid 29044431)
24. Bahn MM, Parchi P. Abnormal diffusion-weighted magnetic resonance images in Creutzfeldt-Jakob disease. Arch Neurol. 1999;56(5):577-83. (Pubitemid 29218153)
25. Mittal S, Farmer P, Kalina P, Kingsley PB, Halperin J. Correlation of diffusion-weighted magnetic resonance imaging with neuropathology in Creutzfeldt-Jakob disease. Arch Neurol. 2002;59(1):128-34. (Pubitemid 34052565)
26. Geschwind MD, Potter CA, Sattavat M, et al. Correlating DWI MRI with pathologic and other features of Jakob-Creutzfeldt disease. Alzheimer Dis Assoc Disord. 2009;23(1):82-7.
27. Haik S, Brandel JP, Oppenheim C, et al. Sporadic CJD clinically mimicking variant CJD with bilateral increased signal in the pulvinar. Neurology. 2002;58(1):148-9. (Pubitemid 34041959)
28. Kropp S, Schulz-Schaeffer WJ, Finkenstaedt M, et al. The Heidenhain variant of Creutzfeldt-Jakob disease. Arch Neurol. 1999;56(1):55-61. (Pubitemid 29046909)
29. Cooper SA, Murray KL, Heath CA, Will RG, Knight RS. Isolated visual symptoms at onset in sporadic Creutzfeldt-Jakob disease: The clinical phenotype of the "Heidenhain variant". Br J Ophthalmol. 2005;89(10):1341-2. (Pubitemid 41638877)
30. Samuel W, Alford M, Hofstetter CR, Hansen L. Dementia with Lewy bodies versus pure Alzheimer disease: Differences in cognition, neuropathology, cholinergic dysfunction, and synapse density. J Neuropathol Exp Neurol. 1997;56(5):499-508. (Pubitemid 27463091)
31. Kotzbauer PT, Trojanowsk JQ, Lee VM. Lewy body pathology in Alzheimer's disease. J Mol Neurosci. 2001;17(2):225-32. (Pubitemid 33063526)